GenMark Diagnostics Q3 EPS $(0.2) Misses $(0.19) Estimate, Sales $20.918M Beat $20.59M Estimate

GenMark Diagnostics (NASDAQ:GNMK) reported quarterly losses of $(0.2) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is unchanged from the same period last year. The company

Benzinga · 11/06/2019 22:02

GenMark Diagnostics (NASDAQ:GNMK) reported quarterly losses of $(0.2) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is unchanged from the same period last year. The company reported quarterly sales of $20.918 million which beat the analyst consensus estimate of $20.59 million by 1.59 percent. This is a 32.43 percent increase over sales of $15.795 million the same period last year.